Dr. Yavor Vladimirov will present an innovation at the invitation of the international community

Dr. Yavor Vladimirov will present to the international community of scientists and doctors the results of a study that analyzes the dynamics of E1-3G and the limits of its growth during ovarian stimulation in the treatment of infertility, using an in vitro procedure.

This will take place in Copenhagen, at the annual ESHRE congress.

ESHRE is the European Society for Human Reproduction and Embryology.
The ESHRE Conference is a great forum and a place for the exchange of ideas and knowledge, a place to establish cooperation.

The study by Dr. Vladimirov and his team is on whether direct and indirect costs, as well as frequent visits to the in vitro clinic, can be reduced by remote monitoring.

Question about the study:Can regular determination of E1-3G levels in the urine of a patient be used to successfully monitor the progestin ovarian stimulation (PPOS) protocol?

Summarized answer:
Regular determination of E1-3G levels in urine can be successfully used in ovarian stimulation (OS), significantly reducing patient visits to the clinic.

Dr. Vladimirov's research is a novelty and revolution in the world of in vitro procedure. This could be a chance for many couples who do not have the physical and financial ability to visit the clinic every other day in vitro for ultrasound examinations and monitoring of hormone levels in the blood. Find out more about the method here.

‍